TCL Archive Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer September 26, 2008
TCL Archive Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone April 10, 1987
TCL Archive In Brief: Chamberlain, Kupchella Lead Educators; Mattel Donates $25 Million To UCLA Children’s November 20, 1998
TCL Archive NIH Draft Guidelines On Stem Cell Research Limit Funds To Cells From In Vitro Fertilization April 24, 2009
